Skip to main content
SPT logo

SPT — Investor Relations & Filings

Ticker · 1789 ISIN · TW0001789006 TW Manufacturing
Filings indexed 2,231 across all filing types
Latest filing 2024-08-12 Regulatory Filings
Country TW Taiwan
Listing TW 1789

ScinoPharm Taiwan, Ltd. is a global provider of high-quality Active Pharmaceutical Ingredients (APIs) and comprehensive Contract Development and Manufacturing Organization (CDMO) services. The company specializes in process research, development, and cGMP production, maintaining a leadership position in oncology APIs. Its portfolio covers therapeutic areas including cancer, hematology, metabolic disorders, and central nervous system diseases. ScinoPharm offers one-stop solutions encompassing peptide synthesis, API process development, and the manufacturing of sterile injectables and complex generics. The company is distinguished by its expertise in high-barrier pharmaceutical technologies and adherence to stringent international regulatory standards, such as the U.S. FDA. Serving both generic and innovative drug sectors, it leverages advanced R&D and integrated manufacturing to support global healthcare markets.

Recent filings

Filing Released Lang Actions
113年第2季大陸投資
Regulatory Filings Classification · 95% confidence The document is a detailed tabular disclosure of investment amounts and related financial data concerning the company's investments in mainland China. It includes specific financial figures, investment methods, and regulatory approval limits. The content is regulatory in nature, providing compliance information about overseas investments, but it does not constitute a full financial report, earnings release, or management discussion. The document length is short (1483 characters), and it is a regulatory disclosure rather than a report or announcement of a report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-08-12 Chinese
113年第2季海外子公司投資
Regulatory Filings Classification · 95% confidence The document is a financial disclosure related to investment in overseas subsidiaries, showing investment amounts, shareholding percentages, and recognized investment gains or losses for the current period. It is relatively short (766 characters) and appears to be a regulatory disclosure of investment details rather than a full financial report. There is no indication of it being an annual or interim report, audit report, or earnings release. It does not contain management commentary or detailed financial statements. The content fits best as a Regulatory Filing (RNS) because it is a specific financial disclosure that does not fit into other categories and is likely a compliance or regulatory announcement.
2024-08-12 Chinese
113年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company (神隆) providing information about loan balances and endorsement guarantees for the current and previous month, including limits and cumulative amounts. It is a short, factual update without detailed financial statements or analysis. There is no indication of a full report, audit, or management discussion. The content fits the profile of a regulatory announcement or compliance disclosure rather than a full financial report or presentation. Given the short length (624 characters) and the nature of the data, this is best classified as a Regulatory Filing (RNS).
2024-08-09 Chinese
113年7月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 神隆, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The length is short (773 characters), and it appears to be a regulatory or public disclosure of revenue figures rather than a full financial report. There is no indication that this is an announcement of a report publication or a certification. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth of an Interim Report or Annual Report.
2024-08-09 Chinese
113年07月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tabular data showing shareholdings of insiders, including directors, independent directors, and the general manager, with specific numbers of shares held, changes in holdings, and related notes. The content focuses on personal share transactions and holdings by company directors and executives. There is no indication of financial results, management discussion, legal proceedings, or other report types. The document is not a report publication announcement or a certification but a direct disclosure of insider shareholdings. Therefore, it fits the definition of Director's Dealing (DIRS).
2024-08-07 Chinese
113年07月董事會成員及持股
Major Shareholding Notification Classification · 95% confidence The document contains detailed tabular data about shareholdings of insiders, including directors, independent directors, general managers, and major shareholders. It lists the number of shares held, pledged shares, and related percentages. The content is focused on insider shareholdings and their changes, which is typical of a Director's Dealing or insider shareholding notification. There is no indication of financial results, management discussion, or report publication. The document is not a report but a disclosure of insider shareholdings. Therefore, the most appropriate classification is Major Shareholding Notification (MRQ). The document length is sufficient and the content is substantive insider shareholding data, not a brief announcement or certification.
2024-08-07 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.